Min Kang

Min Kang

Texas Tech University Health Sciences Center - Lubbock / United States
Others
AD Scientific Index ID: 1737361
person_outline Min Kang's MOST POPULAR ARTICLES
1-) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapyMH Kang, CP ReynoldsClinical cancer research 15 (4), 1126-1132, 200911922009
2-) Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasmsV Sandor, S Bakke, RW Robey, MH Kang, MV Blagosklonny, J Bender, ...Clinical Cancer Research 8 (3), 718-728, 20026662002
3-) Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)JM Maris, CL Morton, R Gorlick, EA Kolb, R Lock, H Carol, ST Keir, ...Pediatric blood & cancer 55 (1), 26-34, 20102562010
4-) A phase I trial of depsipeptide (FR901228) in patients with advanced cancerJL Marshall, N Rizvi, J Kauh, W Dahut, M Figuera, MH Kang, WD Figg, ...Journal of Experimental Therapeutics and Oncology 2 (6), 325-332, 20022562002
5-) Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivoMH Kang, YH Kang, B Szymanska, U Wilczynska-Kalak, MA Sheard, ...Blood, The Journal of the American Society of Hematology 110 (6), 2057-2066, 20071912007